Page last updated: 2024-09-03

ginsenoside rh2 and gemcitabine

ginsenoside rh2 has been researched along with gemcitabine in 1 studies

Compound Research Comparison

Studies
(ginsenoside rh2)
Trials
(ginsenoside rh2)
Recent Studies (post-2010)
(ginsenoside rh2)
Studies
(gemcitabine)
Trials
(gemcitabine)
Recent Studies (post-2010) (gemcitabine)
295120012,5233,2086,923

Protein Interaction Comparison

ProteinTaxonomyginsenoside rh2 (IC50)gemcitabine (IC50)
Chain A, DEOXYNUCLEOSIDE KINASEDrosophila melanogaster (fruit fly)0.76
Equilibrative nucleoside transporter 1Homo sapiens (human)0.19

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fagone, P; He, J; Li, Q; Li, S; Lu, Y; Nicoletti, F; Tian, C; Xiang, M; Yang, J; Yuan, H1

Other Studies

1 other study(ies) available for ginsenoside rh2 and gemcitabine

ArticleYear
The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway.
    Clinical immunology (Orlando, Fla.), 2023, Volume: 248

    Topics: Animals; B-Cell CLL-Lymphoma 10 Protein; CARD Signaling Adaptor Proteins; Cell Line, Tumor; Dendritic Cells; Gemcitabine; Immunity; Mice; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; NF-kappa B; Pancreatic Neoplasms; Tumor Microenvironment

2023